TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Charles N Landen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.